AdaptHealth (AHCO) Stock Forecast, Price Target & Predictions
AHCO Stock Forecast
AdaptHealth stock forecast is as follows: an average price target of $13.00 (represents a 26.46% upside from AHCO’s last price of $10.28) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.
AHCO Price Target
The average price target for AdaptHealth (AHCO) is $13.00 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $14.00 to $12.00. This represents a potential 26.46% upside from AHCO's last price of $10.28.
AHCO Analyst Ratings
According to 4 Wall Street analysts, AdaptHealth's rating consensus is 'Buy'. The analyst rating breakdown for AHCO stock is 0 'Strong Buy' (0.00%), 4 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
AdaptHealth Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Nov 15, 2024 | David MacDonald | Truist Financial | $12.00 | $9.80 | 22.45% | 16.73% |
| Nov 06, 2024 | Eric Coldwell | Robert W. Baird | $14.00 | $9.07 | 54.36% | 36.19% |
| Sep 23, 2024 | Eric Coldwell | Robert W. Baird | $16.00 | $11.42 | 40.11% | 55.64% |
| Aug 08, 2024 | Kevin Caliendo | UBS | $13.00 | $9.53 | 36.41% | 26.46% |
| Sep 20, 2022 | Deutsche Bank | $28.00 | $21.81 | 28.38% | 172.37% | |
| Sep 19, 2022 | Truist Financial | $28.00 | $20.98 | 33.46% | 172.37% | |
| Aug 10, 2022 | RBC Capital | $29.00 | $22.24 | 30.40% | 182.10% | |
| Aug 10, 2022 | Leerink Partners | $29.00 | $22.24 | 30.40% | 182.10% | |
| Jul 26, 2022 | David MacDonald | Truist Financial | $24.00 | $21.00 | 14.29% | 133.46% |
The latest AdaptHealth stock forecast, released on Nov 15, 2024 by David MacDonald from Truist Financial, set a price target of $12.00, which represents a 22.45% increase from the stock price at the time of the forecast ($9.80), and a 16.73% increase from AHCO last price ($10.28).
AdaptHealth Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 3 | 4 |
| Avg Price Target | - | $14.00 | $13.75 |
| Last Closing Price | $10.28 | $10.28 | $10.28 |
| Upside/Downside | -100.00% | 36.19% | 33.75% |
In the current month, the average price target of AdaptHealth stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to AdaptHealth's last price of $10.28. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 08, 2024 | UBS | Buy | Buy | Hold |
| May 15, 2024 | UBS | Buy | Buy | Hold |
| Mar 04, 2024 | UBS | Buy | Buy | Hold |
| Mar 04, 2024 | RBC Capital | Underperform | Underperform | Hold |
| Sep 20, 2022 | Deutsche Bank | Buy | Buy | Hold |
| Sep 19, 2022 | Susquehanna | Buy | Buy | Hold |
| Aug 10, 2022 | RBC Capital | Outperform | Outperform | Hold |
| Aug 10, 2022 | SVB Leerink | Outperform | Outperform | Hold |
| Feb 18, 2022 | SVB Leerink | Outperform | Outperform | Hold |
AdaptHealth's last stock rating was published by UBS on Aug 08, 2024. The company gave AHCO a "Buy" rating, the same as its previous rate.
AdaptHealth Financial Forecast
AdaptHealth Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $858.23M | $804.03M | $793.29M | $744.63M | $780.28M | $557.65M | $727.61M | $706.20M | $702.11M | $653.29M | $617.02M | $482.12M | $348.43M | $284.40M | $232.12M | $191.44M | $529.64M |
| Avg Forecast | $916.74M | $882.22M | $869.26M | $832.32M | $871.59M | $837.89M | $825.76M | $802.28M | $829.19M | $809.32M | $802.62M | $769.87M | $825.45M | $796.60M | $765.17M | $756.47M | $788.13M | $737.93M | $724.22M | $651.42M | $689.92M | $638.74M | $574.03M | $486.34M | $323.10M | $265.25M | $196.28M | $177.41M | $142.25M |
| High Forecast | $942.10M | $906.63M | $893.31M | $855.35M | $895.71M | $861.07M | $848.61M | $830.98M | $837.29M | $812.85M | $802.62M | $769.87M | $830.51M | $796.60M | $786.34M | $777.40M | $809.94M | $737.93M | $724.22M | $651.42M | $689.92M | $638.74M | $574.03M | $486.34M | $323.10M | $265.25M | $196.28M | $177.41M | $142.25M |
| Low Forecast | $892.68M | $859.07M | $846.45M | $810.47M | $848.71M | $815.90M | $804.08M | $775.13M | $817.89M | $805.79M | $802.62M | $769.87M | $817.52M | $796.60M | $745.08M | $736.61M | $767.44M | $737.93M | $724.22M | $651.42M | $689.92M | $638.74M | $574.03M | $486.34M | $323.10M | $265.25M | $196.28M | $177.41M | $142.25M |
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 7 | 3 | 3 | 4 | 7 | 5 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 3 | 3 | 3 | 2 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.04% | 1.01% | 1.04% | 0.98% | 0.99% | 0.76% | 1.00% | 1.08% | 1.02% | 1.02% | 1.07% | 0.99% | 1.08% | 1.07% | 1.18% | 1.08% | 3.72% |
AdaptHealth's average Quarter revenue forecast for Mar 24 based on 4 analysts is $769.87M, with a low forecast of $769.87M, and a high forecast of $769.87M. AHCO's average Quarter revenue forecast represents a -10.30% decrease compared to the company's last Quarter revenue of $858.23M (Dec 23).
AdaptHealth EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 7 | 3 | 3 | 4 | 7 | 5 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 3 | 3 | 3 | 2 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $-227.64M | $-441.83M | $67.48M | $118.81M | $50.44M | $145.02M | $137.39M | $122.92M | $135.80M | $164.32M | $178.38M | $63.73M | $-41.92M | $32.03M | $31.71M | $25.63M | $-6.43M |
| Avg Forecast | $89.18M | $85.82M | $84.56M | $80.97M | $84.79M | $81.51M | $80.33M | $78.05M | $80.66M | $78.73M | $78.08M | $252.68M | $80.30M | $77.49M | $74.43M | $229.70M | $201.67M | $94.93M | $93.17M | $208.82M | $88.75M | $82.17M | $73.85M | $124.69M | $41.56M | $34.12M | $25.25M | $46.85M | $-19.86M |
| High Forecast | $91.65M | $88.20M | $86.90M | $83.21M | $87.13M | $83.76M | $82.55M | $80.84M | $81.45M | $79.07M | $78.08M | $303.21M | $80.79M | $77.49M | $76.49M | $275.65M | $242.00M | $94.93M | $93.17M | $250.59M | $88.75M | $82.17M | $73.85M | $149.63M | $41.56M | $34.12M | $25.25M | $56.22M | $-15.88M |
| Low Forecast | $86.84M | $83.57M | $82.34M | $78.84M | $82.56M | $79.37M | $78.22M | $75.40M | $79.56M | $78.39M | $78.08M | $202.14M | $79.53M | $77.49M | $72.48M | $183.76M | $161.33M | $94.93M | $93.17M | $167.06M | $88.75M | $82.17M | $73.85M | $99.75M | $41.56M | $34.12M | $25.25M | $37.48M | $-23.83M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -2.83% | -5.70% | 0.91% | 0.52% | 0.25% | 1.53% | 1.47% | 0.59% | 1.53% | 2.00% | 2.42% | 0.51% | -1.01% | 0.94% | 1.26% | 0.55% | 0.32% |
5 analysts predict AHCO's average Quarter EBITDA for Sep 23 to be $77.49M, with a high of $77.49M and a low of $77.49M. This is 14.84% upper than AdaptHealth's previous annual EBITDA (Jun 23) of $67.48M.
AdaptHealth Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 7 | 3 | 3 | 4 | 7 | 5 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 3 | 3 | 3 | 2 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-254.50M | $-454.08M | $13.98M | $15.71M | $-1.57M | $16.12M | $14.03M | $41.75M | $23.47M | $58.09M | $79.11M | $-3.97M | $-65.87M | $-2.49M | $4.03M | $-158.16K | $-15.00M |
| Avg Forecast | $69.64M | $51.87M | $47.48M | $37.09M | $47.42M | $33.99M | $31.72M | $23.82M | $37.51M | $26.03M | $26.24M | $70.72M | $26.28M | $26.98M | $17.97M | $64.30M | $34.07M | $41.70M | $39.97M | $58.45M | $51.52M | $47.01M | $34.11M | $-7.76M | $26.62M | $14.00M | $15.42M | $-289.16K | $-46.28M |
| High Forecast | $72.14M | $53.74M | $49.19M | $38.43M | $49.13M | $35.21M | $32.86M | $24.68M | $41.39M | $26.15M | $26.60M | $84.87M | $30.23M | $27.08M | $18.62M | $77.15M | $40.88M | $41.70M | $39.97M | $70.14M | $51.52M | $47.01M | $34.11M | $-6.21M | $26.62M | $14.00M | $15.42M | $-231.32K | $-37.03M |
| Low Forecast | $67.26M | $50.11M | $45.86M | $35.83M | $45.81M | $32.83M | $30.64M | $22.57M | $36.22M | $25.92M | $25.89M | $56.58M | $18.40M | $26.87M | $17.36M | $51.44M | $27.26M | $41.70M | $39.97M | $46.76M | $51.52M | $47.01M | $34.11M | $-9.31M | $26.62M | $14.00M | $15.42M | $-346.99K | $-55.54M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -9.68% | -16.83% | 0.78% | 0.24% | -0.05% | 0.39% | 0.35% | 0.71% | 0.46% | 1.24% | 2.32% | 0.51% | -2.47% | -0.18% | 0.26% | 0.55% | 0.32% |
AdaptHealth's average Quarter net income forecast for Sep 23 is $26.98M, with a range of $26.87M to $27.08M. AHCO's average Quarter net income forecast represents a 93.01% increase compared to the company's last Quarter net income of $13.98M (Jun 23).
AdaptHealth SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 7 | 3 | 3 | 4 | 7 | 5 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 3 | 3 | 3 | 2 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $47.29M | $45.20M | $50.08M | $47.52M | $37.45M | $40.68M | $42.55M | $41.44M | $34.92M | $33.01M | $42.95M | $56.63M | $31.60M | $26.31M | $17.09M | $14.35M | $53.21M |
| Avg Forecast | $64.27M | $61.85M | $60.94M | $58.35M | $61.11M | $58.74M | $57.89M | $56.25M | $58.13M | $56.74M | $56.27M | $70.21M | $57.87M | $55.85M | $53.65M | $63.82M | $51.86M | $51.36M | $50.41M | $58.02M | $48.02M | $44.46M | $39.96M | $110.80M | $22.49M | $18.46M | $13.66M | $26.23M | $9.90M |
| High Forecast | $66.05M | $63.56M | $62.63M | $59.97M | $62.80M | $60.37M | $59.50M | $58.26M | $58.70M | $56.99M | $56.27M | $84.25M | $58.23M | $55.85M | $55.13M | $76.59M | $62.23M | $51.36M | $50.41M | $69.63M | $48.02M | $44.46M | $39.96M | $132.96M | $22.49M | $18.46M | $13.66M | $31.48M | $9.90M |
| Low Forecast | $62.59M | $60.23M | $59.34M | $56.82M | $59.50M | $57.20M | $56.37M | $54.34M | $57.34M | $56.49M | $56.27M | $56.16M | $57.32M | $55.85M | $52.24M | $51.06M | $41.49M | $51.36M | $50.41M | $46.42M | $48.02M | $44.46M | $39.96M | $88.64M | $22.49M | $18.46M | $13.66M | $20.98M | $9.90M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.82% | 0.81% | 0.93% | 0.74% | 0.72% | 0.79% | 0.84% | 0.71% | 0.73% | 0.74% | 1.07% | 0.51% | 1.41% | 1.42% | 1.25% | 0.55% | 5.37% |
AdaptHealth's average Quarter SG&A projection for Mar 24 is $70.21M, based on 4 Wall Street analysts, with a range of $56.16M to $84.25M. The forecast indicates a 48.45% rise compared to AHCO last annual SG&A of $47.29M (Dec 23).
AdaptHealth EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 7 | 3 | 3 | 4 | 7 | 5 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 3 | 3 | 3 | 2 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-1.91 | $-3.37 | $0.10 | $0.11 | $-0.01 | $0.11 | $0.10 | $0.29 | $0.18 | $0.40 | $0.56 | $-0.04 | $-0.47 | $-0.04 | $0.09 | $-0.00 | $-0.10 |
| Avg Forecast | $0.51 | $0.38 | $0.35 | $0.27 | $0.35 | $0.25 | $0.23 | $0.17 | $0.27 | $0.19 | $0.19 | $0.06 | $0.19 | $0.20 | $0.13 | $0.10 | $0.31 | $0.31 | $0.29 | $0.21 | $0.38 | $0.35 | $0.25 | $0.25 | $0.20 | $0.10 | $0.11 | $0.12 | $0.06 |
| High Forecast | $0.53 | $0.39 | $0.36 | $0.28 | $0.36 | $0.26 | $0.24 | $0.18 | $0.30 | $0.19 | $0.19 | $0.06 | $0.22 | $0.20 | $0.14 | $0.10 | $0.32 | $0.31 | $0.29 | $0.21 | $0.38 | $0.35 | $0.25 | $0.25 | $0.20 | $0.10 | $0.11 | $0.12 | $0.06 |
| Low Forecast | $0.49 | $0.37 | $0.34 | $0.26 | $0.34 | $0.24 | $0.22 | $0.17 | $0.27 | $0.19 | $0.19 | $0.05 | $0.13 | $0.20 | $0.13 | $0.09 | $0.30 | $0.31 | $0.29 | $0.21 | $0.38 | $0.35 | $0.25 | $0.25 | $0.20 | $0.10 | $0.11 | $0.12 | $0.06 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -9.92% | -17.06% | 0.76% | 1.13% | -0.04% | 0.36% | 0.34% | 1.41% | 0.48% | 1.16% | 2.23% | -0.16% | -2.40% | -0.39% | 0.79% | -0.03% | -1.55% |
According to 5 Wall Street analysts, AdaptHealth's projected average Quarter EPS for Sep 23 is $0.20, with a low estimate of $0.20 and a high estimate of $0.20. This represents a 97.59% increase compared to AHCO previous annual EPS of $0.10 (Jun 23).
AdaptHealth Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| APYX | Apyx Medical | $1.64 | $8.50 | 418.29% | Buy |
| LUNG | Pulmonx | $6.13 | $13.00 | 112.07% | Buy |
| SGHT | Sight Sciences | $3.62 | $7.50 | 107.18% | Hold |
| KIDS | OrthoPediatrics | $22.46 | $39.50 | 75.87% | Buy |
| LIVN | LivaNova | $49.94 | $68.25 | 36.66% | Buy |
| OFIX | Orthofix Medical | $17.93 | $24.00 | 33.85% | |
| NPCE | NeuroPace | $11.52 | $15.00 | 30.21% | Buy |
| AHCO | AdaptHealth | $10.04 | $13.00 | 29.48% | Buy |
| AVNS | Avanos Medical | $17.02 | $20.00 | 17.51% | Hold |
| ITGR | Integer | $136.68 | $153.50 | 12.31% | Buy |
| FNA | Paragon 28 | $10.36 | $11.50 | 11.00% | Buy |
| AORT | Artivion | $28.90 | $30.75 | 6.40% | Buy |
| SRDX | Surmodics | $39.96 | $39.50 | -1.15% | Buy |